Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Miglitol calcium vs nateglinide in type 2 diabetes
CTR20131657Phase 2Completed
- Sponsor
- Aimin Pharmaceutical
- Start
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of miglitol in type 2 diabetes mellitus (T2DM), postprandial hyperglycemia (PPH), sponsored by Aimin Pharmaceutical. Started Oct 2014; status: completed.
02
Drugs
miglitol
03
Conditions
type 2 diabetes mellitus (T2DM)postprandial hyperglycemia (PPH)
Beyond the preview
Go deeper on CTR20131657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131657.